We are live on ! Find out more
MSKCC

Memorial Sloan Kettering Cancer Center Portfolio holdings

AUM $24.6M
1-Year Est. Return 10.16%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+10.16%
3 Year Est. Return
-14.79%
5 Year Est. Return
10 Year Est. Return
AUM
$32.6M
AUM Growth
+$2.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
5
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 26.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDX icon
1
VanEck Gold Miners ETF
GDX
$27.6B
$23.9M 73.26%
738,500
ORIC icon
2
Oric Pharmaceuticals
ORIC
$1.41B
$3.43M 10.53%
602,272
CRBU icon
3
Caribou Biosciences
CRBU
$165M
$2.89M 8.86%
544,196
ILMN icon
4
Illumina
ILMN
$29B
$1.44M 4.41%
6,360
YMAB
5
DELISTED
Y-mAbs Therapeutics
YMAB
$958K 2.94%
191,176

Similar funds

Memorial Sloan Kettering Cancer Center's Q1 2023 Portfolio in Review

As of Q1 2023, Memorial Sloan Kettering Cancer Center held 5 positions worth $32.6M, up 7.6% from $30.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q1 2023: portfolio turnover was 0%. Memorial Sloan Kettering Cancer Center opened no new positions and made no exits, leaving the 5-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier.

  • Memorial Sloan Kettering Cancer Center's ten largest holdings make up 100% of its $32.6M portfolio in Q1 2023.
  • Memorial Sloan Kettering Cancer Center opened 0 new positions and closed 0 in Q1 2023.
  • Memorial Sloan Kettering Cancer Center's portfolio value rose 7.6% quarter-over-quarter to $32.6M.

Based on Memorial Sloan Kettering Cancer Center's 13F filing for Q1 2023, filed 15 May 2023.